Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Arjun Goyal currently holds 48,000 shares of Centessa Pharmaceuticals plc (CNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arjun Goyal has been a net buyer of CNTA stock. They have purchased $15.0M and sold $0 worth of shares.
Arjun Goyal's most recent insider trade was on Jun 25, 2024, when they sold 48,000 shares at $0.00 per share.
Arjun Goyal serves as Executive at Centessa Pharmaceuticals plc (CNTA). They have executed 5 insider transactions totaling $15.0M over their tenure at the company.
Arjun Goyal holds the position of Executive at Centessa Pharmaceuticals plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Arjun Goyal has shown a buying trading pattern, with $15.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Arjun Goyal was on Jun 2, 2021, when they purchased $14.6M worth of CNTA shares. This transaction involved 729,750 shares at $20.00 per share.
Arjun Goyal currently owns 48,000 shares of Centessa Pharmaceuticals plc (CNTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Arjun Goyal's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Arjun Goyal has 5 Form 4 filings on record as an insider at Centessa Pharmaceuticals plc.
Set alerts for Arjun Goyal and 40,000+ other insiders.